Profile data is unavailable for this security.
About the company
Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.
- Revenue in AUD (TTM)6.06m
- Net income in AUD-7.42m
- Incorporated2006
- Employees--
- LocationOrthocell LtdBuilding 191 Murdoch UniversitySouth Street MurdochPERTH 6150AustraliaAUS
- Phone+61 89360-2888
- Fax+61 89360-2899
- Websitehttp://www.orthocell.com.au/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDT Australia Limited | 10.36m | -6.55m | 49.40m | 156.00 | -- | 1.75 | -- | 4.77 | -0.022 | -0.022 | 0.035 | 0.0656 | 0.3741 | 2.39 | 3.51 | -- | -23.64 | -9.87 | -26.41 | -11.57 | 76.38 | 84.42 | -63.19 | -24.94 | 2.81 | -- | 0.0907 | -- | -42.03 | -11.97 | -632.59 | -- | -26.04 | -- |
| Biotron Ltd | 1.65m | -4.02m | 49.63m | 4.00 | -- | 26.55 | -- | 30.17 | -0.0045 | -0.0045 | 0.0018 | 0.0021 | 0.3587 | -- | -- | -- | -87.73 | -64.30 | -103.46 | -74.43 | -156.30 | -108.03 | -244.54 | -231.62 | -- | -- | 0.0148 | -- | -8.16 | -2.48 | -25.59 | -- | -- | -- |
| Inoviq Ltd | 751.54k | -6.51m | 51.99m | 85.00 | -- | 3.10 | -- | 69.18 | -0.0708 | -0.0708 | 0.0082 | 0.182 | 0.0339 | 2.10 | 0.873 | -- | -29.33 | -47.68 | -32.18 | -50.76 | 95.07 | -- | -866.27 | -2,527.82 | 4.93 | -- | 0.0332 | -- | 119.59 | 153.31 | 50.71 | -- | -- | -- |
| Cynata Therapeutics Ltd | 436.25k | -13.65m | 53.89m | 0.00 | -- | 4.39 | -- | 123.53 | -0.0873 | -0.0873 | 0.0027 | 0.0683 | 0.0257 | -- | 4.26 | -- | -80.33 | -38.07 | -87.15 | -41.10 | -- | -- | -3,127.93 | -513.73 | -- | -- | 0.00 | -- | -94.96 | 19.81 | -162.20 | -- | -- | -- |
| Vitura Health Ltd | 119.67m | 9.40m | 55.28m | 121.00 | 5.83 | 1.41 | 14.62 | 0.462 | 0.0165 | 0.0165 | 0.2099 | 0.0681 | 1.98 | 11.22 | 10.51 | 989,034.20 | 15.25 | 15.29 | 22.30 | 21.06 | 31.23 | -- | 7.70 | 6.92 | 1.18 | 5,598.19 | 0.2359 | -- | 75.16 | -- | 128.31 | 146.95 | 54.86 | -- |
| Anteotech Ltd | 526.75k | -11.46m | 56.68m | 40.00 | -- | 10.63 | -- | 107.60 | -0.0056 | -0.0056 | 0.0003 | 0.0022 | 0.0552 | -- | 2.62 | -- | -120.11 | -68.55 | -145.22 | -75.44 | -- | -- | -2,176.15 | -1,432.10 | -- | -- | 0.1729 | -- | -46.65 | 11.41 | -18.08 | -- | 25.84 | -- |
| Neurotech International Ltd | 1.28m | -4.98m | 63.08m | -- | -- | 11.53 | -- | 49.38 | -0.0058 | -0.0058 | 0.0015 | 0.0054 | 0.1826 | -0.1149 | 5.67 | -- | -71.23 | -197.33 | -74.66 | -255.24 | 100.07 | 79.57 | -390.03 | -1,043.88 | 18.35 | -- | 0.00 | -- | 106.22 | 83.24 | -131.75 | -- | -- | -- |
| Biome Australia Ltd | 10.24m | -2.86m | 69.17m | 30.00 | -- | 32.08 | -- | 6.75 | -0.0141 | -0.0141 | 0.0506 | 0.0101 | 1.37 | 1.93 | 6.04 | 341,434.70 | -38.27 | -- | -74.60 | -- | 61.29 | -- | -27.97 | -- | 0.9514 | -15.92 | 0.4032 | -- | 73.58 | -- | 32.20 | -- | -- | -- |
| Orthocell Ltd | 6.06m | -7.42m | 75.36m | -- | -- | 32.93 | -- | 12.44 | -0.0369 | -0.0369 | 0.0301 | 0.0109 | 0.2182 | 1.50 | 27.68 | -- | -26.73 | -32.67 | -31.96 | -38.53 | 77.11 | 63.04 | -122.55 | -374.46 | 4.36 | -- | 0.2586 | -- | 215.24 | 51.53 | 31.39 | -- | 11.07 | -- |
| Percheron Therapeutics Ltd | 624.51k | -10.85m | 76.63m | 8.00 | -- | 4.66 | -- | 122.71 | -0.0157 | -0.0157 | 0.0009 | 0.0182 | 0.0328 | -- | 0.3224 | -- | -56.94 | -72.09 | -66.58 | -81.73 | -- | -- | -1,737.37 | -6,558.90 | -- | -- | 0.001 | -- | 1,026.16 | 72.03 | -95.81 | -- | -- | -- |
| Next Science Ltd | 33.37m | -24.48m | 77.30m | -- | -- | 4.01 | -- | 2.32 | -0.1058 | -0.1058 | 0.1425 | 0.0661 | 1.46 | 7.47 | 8.33 | -- | -107.19 | -74.40 | -136.06 | -90.31 | 73.20 | 76.98 | -73.36 | -128.26 | 3.45 | -50.37 | 0.0698 | -- | 89.36 | 50.80 | -28.29 | -- | -2.28 | -- |
| Actinogen Medical Ltd | 337.51k | -14.87m | 77.78m | -- | -- | 5.66 | -- | 230.45 | -0.0073 | -0.0073 | 0.0002 | 0.0051 | 0.0211 | -- | 0.7341 | -- | -92.99 | -45.55 | -105.88 | -48.24 | -- | -- | -4,405.86 | -5,369.76 | -- | -294.93 | 0.0037 | -- | 792.74 | 31.88 | -13.21 | -- | 166.95 | -- |
| PharmAust Limited | 1.85m | -7.79m | 81.16m | 52.00 | -- | 10.28 | -- | 43.85 | -0.0236 | -0.0201 | 0.0055 | 0.02 | 0.1977 | -- | 6.71 | -- | -83.26 | -25.56 | -96.46 | -28.78 | 20.06 | 90.73 | -421.04 | -59.16 | -- | -104.65 | 0.00 | -- | -13.53 | 3.42 | -263.63 | -- | -47.47 | -- |
| Paradigm Biopharmaceuticals Ltd | 8.67m | -69.00m | 85.70m | -- | -- | 2.55 | -- | 9.89 | -0.2296 | -0.2296 | 0.0288 | 0.0962 | 0.1298 | -- | 2.25 | -- | -103.34 | -40.96 | -127.58 | -44.13 | 99.87 | -- | -796.30 | -466.85 | -- | -348.76 | 0.0085 | -- | 7.58 | 25.42 | -32.26 | -- | -- | -- |
| Argenica Therapeutics Ltd | 92.21k | -4.67m | 89.66m | -- | -- | 10.98 | -- | 972.31 | -0.0511 | -0.0511 | 0.001 | 0.0665 | 0.0109 | -- | 0.6384 | -- | -55.31 | -- | -69.00 | -- | -- | -- | -5,067.62 | -- | -- | -6,663.20 | 0.00 | -- | 2,340.00 | -- | -17.71 | -- | -- | -- |
Data as of Jun 07 2024. Currency figures normalised to Orthocell Ltd's reporting currency: Australian Dollar AUD
2.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sandhurst Trustees Ltd.as of 23 Aug 2023 | 4.91m | 2.35% |
Data from 29 Feb 2024 - 29 Feb 2024Source: FactSet Research Systems Inc.
